Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 71335-2674

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 71335-2674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352674)

Label for Spironolactone and Hydrochlorothiazide Tablets USP, 25 mg/25 mg, oral tablets. Package contains 100 tablets. Label shows NDC 71335-2674-1, repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Frontida BioPharm, Inc. Additional text advises storage at 20° to 25°C and dispensing in a tight, light-resistant container. Includes barcodes and QR codes for GTIN and package insert.*

FDA Label Image

Structure (Spironolactone 01)

Chemical structure diagram of the active ingredients in Spironolactone and Hydrochlorothiazide, depicting the molecular framework with characteristic rings and functional groups.*

FDA Label Image

Figure (Spironolactone 02)

Chemical structure of the active ingredients Spironolactone and Hydrochlorothiazide depicted as a molecular diagram showing their atomic arrangement and chemical bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.